Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia [2]

Schizophrenia Research

Volumn 63, Issue 3, 2003, Pages 297-299

  Joyal, Christian C ^a   Hallé, Paul ^a   Lapierre, Dominique ^a   Hodgins, Sheilagh ^a,b  

^a Institut Philippe Pinel de Montreal   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; INTELLIGENCE; LETTER; LIFESTYLE; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; TASK PERFORMANCE;

EID: 0042829439     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00387-0     Document Type: Article

References (16)

1. Andreasen N.C., Flaum M., Swayze V.W. II, Tyrrell G., Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch. Gen. Psychiatry. 47:1990;615-621.
2. Arndt S., Tyrrell G., Flaum M., Andreasen N.C. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol. Med. 22:1992;379-388.
3. Buchanan R.W., Kirkpatrick B., Heinrichs D.W., Carpenter W.T. Clinical correlates of the deficit syndrome of schizophrenia. Am. J. Psychiatry. 147:1990;290-294.
4. Buckley P.B., Thompson P., Way L., Meltzer H.Y. Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for Clozapine therapy. Am. J. Psychiatry. 151:1994;385-389.
5. Convit A., Volavka J., Czobor P., de Asis J., Evangelista C. Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. Am. J. Psychiatry. 151:1994;49-56.
6. Dixon L., Haas G., Weiden P.J., Sweeney J., Frances A.J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry. 148:1991;224-230.
7. Gupta S., Rajaprabhakaran P., Arndt S., Flaum M., Andreasen N. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr. Res. 16:1995;189-197.
8. Hodgins S., Côté G., Toupin J. Major mental disorder and crime: an etiological hypothesis. Cooke D., Forth A., Hare R.D. Psychopathy: Theory, Research, and Implications for Society. 1998;231-256 Kluwer Academic Publishing, Dordrecht, The Netherlands.
9. Kirkpatrick B., Amador X.F., Flaum M., Yale S.A., Gorman J.M., Carpenter W.T. Jr., Tohen M., McGlashan T. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse. Schizophr. Res. 20:1996;69-77.
10. Mueser K.T., Drake R.E., Wallach M.A. Dual diagnosis: a review of etiological theories. Addict. Behav. 23:1998;717-734.
11. Mueser K.T., Yarnold P.R., Rosenberg S.D., Swett C. Jr., Miles K.M., Hill D. Substance use disorder in Hospitalized severely mentally ill psychiatric patients: prevalence, correlates and subgroups. Schizophr. Bull. 26:2000;179-192.
12. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 264:1990;2511-2518.
13. Salyers M.P., Mueser K.T. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr. Res. 48:2001;109-123.
14. Schanda H., Földes P., Topitz A., Fliedl R., Knecht G. Premorbid adjustment of schizophrenic criminal offenders. Acta Psychiatr. Scand. 86:1992;121-126.
15. Scheller-Guilkey G., Lewine R.R.J., Brown C.F.W. Schizophrenia, substance use, and brain morphology. Schizophr. Res. 35:1999;113-120.
16. Zisook S., Heaton R., Moranville J., Kuck J., Jernigan T., Braff D. Past substance abuse and clinical course of schizophrenia. Am. J. Psychiatry. 149:1992;552-553.